Immunotherapy: Harnessing the Power of our own Cells to Treat Cancer
Throughout my first few articles, beginning April 11, I discussed how alterations at the DNA level can at times cause cells to evade normal regulation, as well as their own death, and become cancerous. Scientists, however, have learned how to exploit some of these genetic differences in order to develop cancer therapies such as PARP inhibitors.